Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) Invested Capital: 2009-2025

Historic Invested Capital for Lifecore Biomedical (LFCR) over the last 14 years, with May 2025 value amounting to $131.8 million.

  • Lifecore Biomedical's Invested Capital fell 3.10% to $131.8 million in Q2 2025 from the same period last year, while for May 2025 it was $131.8 million, marking a year-over-year decrease of 3.10%. This contributed to the annual value of $131.8 million for FY2025, which is 3.10% down from last year.
  • As of Q2 2025, Lifecore Biomedical's Invested Capital stood at $131.8 million, which was up 3.62% from $127.2 million recorded in Q1 2025.
  • Lifecore Biomedical's 5-year Invested Capital high stood at $366.8 million for Q2 2021, and its period low was $75.3 million during Q3 2023.
  • Over the past 3 years, Lifecore Biomedical's median Invested Capital value was $120.8 million (recorded in 2024), while the average stood at $112.3 million.
  • In the last 5 years, Lifecore Biomedical's Invested Capital tumbled by 57.34% in 2023 and then skyrocketed by 68.70% in 2024.
  • Over the past 5 years, Lifecore Biomedical's Invested Capital (Quarterly) stood at $279.6 million in 2021, then slumped by 39.17% to $170.1 million in 2022, then crashed by 44.57% to $94.3 million in 2023, then skyrocketed by 34.44% to $126.8 million in 2024, then fell by 3.10% to $131.8 million in 2025.
  • Its last three reported values are $131.8 million in Q2 2025, $127.2 million for Q1 2025, and $126.8 million during Q4 2024.